RT Journal Article
T1 Evaluation of a New Monoclonal Chemiluminescent Immunoassay Stool Antigen Test for the Diagnosis of Helicobacter pylori Infection: A Spanish Multicentre Study.
A1 Resina, Elena
A1 Donday, María G
A1 Martínez-Domínguez, Samuel J
A1 Laserna-Mendieta, Emilio José
A1 Lanas, Ángel
A1 Lucendo, Alfredo J
A1 Sánchez-Luengo, Marta
A1 Alcaide, Noelia
A1 Fernández-Salazar, Luis
A1 De La Peña-Negro, Luisa
A1 Bujanda, Luis
A1 Arbulo, Marta Gómez-Ruiz de
A1 Alcedo, Javier
A1 Pérez-Aísa, Ángeles
A1 Rodríguez, Raúl
A1 Hermida, Sandra
A1 Brenes, Yanire
A1 Nyssen, Olga P
A1 Gisbert, Javier P
K1 Helicobacter pylori
K1 diagnosis
K1 stool antigen test
K1 urea breath test
AB The stool antigen test (SAT) represents an attractive alternative for detection of Helicobacter pylori. The aim of this study was to assess the accuracy of a new SAT, the automated LIAISON® Meridian H. pylori SA based on monoclonal antibodies, compared to the defined gold standard 13C-urea breath test (UBT). This prospective multicentre study (nine Spanish centres) enrolled patients ≥18 years of age with clinical indication to perform UBT for the initial diagnosis and for confirmation of bacterial eradication. Two UBT methods were used: mass spectrometry (MS) including citric acid (CA) or infrared spectrophotometry (IRS) without CA. Overall, 307 patients (145 naïve, 162 with confirmation of eradication) were analysed. Using recommended cut-off values (negative SAT
SN 2077-0383
YR 2022
FD 2022-08-29
LK http://hdl.handle.net/10668/21340
UL http://hdl.handle.net/10668/21340
LA en
DS RISalud
RD Sep 2, 2025